BioGaia AB (FRA:BGLA)
€ 9.115 -0.035 (-0.38%) Market Cap: 931.59 Mil Enterprise Value: 835.03 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q4 2020 Biogaia AB Earnings Call Transcript

Feb 04, 2021 / 08:30AM GMT
Release Date Price: €8.88 (-5.03%)
Operator

Ladies and gentlemen, welcome to the BioGaia Q4 Report 2020. Today, I'm pleased to present Isabelle Ducellier, CEO. (Operator Instructions) Please begin your meeting.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Yes. Thank you, and good morning, everybody. Isabelle and Alex here. So we're going to present you the quarter 4 2020 and speak about the whole year, 2020.

So if you go to Page 2, regarding our executive summary, what is important to remember. First, our total sales are minus 10%. But we have really to emphasize the fact that we've been particularly helped by the weak Swedish krona, especially towards the dollar. And so if you exclude this currency impact, the sales are down on the Q4 by only 4%. And obviously, as we said before, the main explanation, I mean, on top of the exchange is the currency is, as well, the COVID-19. So if we look at the full year perspective, our sales are down with 3% and 2% if you exclude the currency impact.

Looking at region.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot